Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

10/27/2020 | 05:40am EST

DGAP Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27.10.2020 / 11:40
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: Evotec SE
Street: Manfred Eigen Campus / Essener Bogen 7
Postal code: 22419
City: Hamburg
Germany
Legal Entity Identifier (LEI): 529900F9KI6OYITO9B12

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: Mubadala Investment Company PJSC
City of registered office, country: Abu Dhabi, United Arab Emirates

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
ATIC Second International Investment Company LLC

5. Date on which threshold was crossed or reached:
20 Oct 2020

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 5.62 % 0.00 % 5.62 % 163494444
Previous notification n/a % n/a % n/a % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE0005664809 0 9182652 0.00 % 5.62 %
Total 9182652 5.62 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Mubadala Investment Company PJSC % % %
Mamoura Diversified Global Holding PJSC % % %
Mubadala Technology Investments LLC % % %
ATIC Second International Investment Company LLC 5.62 % % 5.62 %
- % % %
Mubadala Investment Company PJSC % % %
Mamoura Diversified Global Holding PJSC % % %
Mubadala Technology Investments LLC % % %
MTI Overseas Investment Limited % % %
ATIC Second International Investment Company LLC 5.62 % % 5.62 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
26 Oct 2020



27.10.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

1143288  27.10.2020 

fncls.ssp?fn=show_t_gif&application_id=1143288&application_name=news&site_id=zonebourse_sftp

© EQS 2020
All news about EVOTEC SE
12/03EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
12/02EVOTEC : publishes DDup 10 – Evotec's transforming transcriptomics toxicol..
PU
11/30EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
11/29EVOTEC : and Rappta Therapeutics enter discovery and development partnership foc..
PU
11/25EVOTEC : and Rappta Therapeutics enter discovery and development partnership foc..
AQ
11/24EVOTEC : And rappta therapeutics enter discovery and development partnership foc..
EQ
11/20EVOTEC : presents growth drivers of 'Autobahn to Cures' at Capital Markets Day
AQ
11/20EVOTEC : Gets a Buy rating from RBC
MD
11/19EVOTEC : Presents growth drivers of 'autobahn to cures' at capital markets day
EQ
11/18EVOTEC : and STORM Therapeutics leverage INDiGO platform to progress oncology pr..
AQ
More news
Financials
Sales 2020 475 M 576 M 576 M
Net income 2020 22,7 M 27,5 M 27,5 M
Net cash 2020 7,50 M 9,09 M 9,09 M
P/E ratio 2020 183x
Yield 2020 -
Capitalization 4 275 M 5 188 M 5 181 M
EV / Sales 2020 8,99x
EV / Sales 2021 7,66x
Nbr of Employees 3 444
Free-Float 85,1%
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 30,67 €
Last Close Price 26,15 €
Spread / Highest target 37,7%
Spread / Average Target 17,3%
Spread / Lowest Target 7,07%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE13.45%5 188
MODERNA, INC.679.75%62 229
LONZA GROUP AG52.83%45 010
CELLTRION, INC.109.94%42 993
SEAGEN INC.56.86%32 484
IQVIA HOLDINGS INC.10.42%32 139